Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe

THOUSAND OAKS, Calif., April 7, 2019 /PRNewswire/ — Amgen
(NASDAQ:AMGN) today announced new data presented from a
cross-sectional study revealing a gap in the diagnosis and
treatment of osteoporosis in Europe. The real-world study of
osteoporosis management in primary care revealed that…

Source: FS – Machinery
Amgen Presents New Data At WCO-IOF-ESCEO 2019 Revealing Osteoporosis Treatment Gap In Europe



Leave a Reply